LPCAT2-C19ORF29 Fusion FISH Probe
The LPCAT2-C19ORF29 Fusion FISH Probe is used to confirm a fusion of the LPCAT2 and C19ORF29 genes. The fusion of the LPCAT2 and C19ORF29 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| LPCAT2-C19ORF29-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-RERE | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-REOR | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-REGO | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-REGR | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-OROR | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-GORE | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-GROR | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| LPCAT2-C19ORF29-20-AQAQ | 20 (40 μL) | 200 μL |
|
LPCAT2 Gene Summary
This gene encodes a member of the lysophospholipid acyltransferase family. The encoded enzyme may function in two ways: to catalyze the biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from 1-O-alkyl-sn-glycero-3-phosphocholine, and to catalyze the synthesis of glycerophospholipid precursors from arachidonyl-CoA and lysophosphatidylcholine. The encoded protein may function in membrane biogenesis and production of platelet-activating factor in inflammatory cells. The enzyme may localize to the endoplasmic reticulum and the Golgi. [provided by RefSeq, Feb 2009]
Gene Name: Lysophosphatidylcholine Acyltransferase 2
Chromosome: CHR16: 55542912 -55620582
Locus: 16q12.2
Gene Diseases
The LPCAT2 C19ORF29 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|